A5007679253- Healthcare Systems and Public Health
- Human Health and Disease
- Lipoproteins and Cardiovascular Health
- Atrial Fibrillation Management and Outcomes
- Cancer, Lipids, and Metabolism
- Cardiac Imaging and Diagnostics
- Cardiac Arrhythmias and Treatments
- Medical and Agricultural Research Studies
- Health Systems, Economic Evaluations, Quality of Life
- Fatty Acid Research and Health
- Neurological Disorders and Treatments
- Diet, Metabolism, and Disease
- Cardiovascular Disease and Adiposity
- Arctic and Russian Policy Studies
- Climate Change and Health Impacts
- Cardiac Health and Mental Health
- GDF15 and Related Biomarkers
- Heart Failure Treatment and Management
- Diabetes Management and Research
- Regional Socio-Economic Development Trends
- Cardiac electrophysiology and arrhythmias
- Regional Economic Development and Innovation
- Children's Physical and Motor Development
- Respiratory and Cough-Related Research
- S100 Proteins and Annexins
Research Institute of Medical Problems of the North
2014-2023
Siberian Branch of the Russian Academy of Sciences
2021-2023
Krasnoyarsk State Medical University
2014-2023
Krasnoyarsk Scientific Center
2020-2023
Russian Academy of Sciences
2014
Arrhythmias are one of the most complex, insufficiently studied, and therefore urgent problems modern cardiology. A wide spectrum clinical manifestations cardiac rhythm disorders (CRDs), their detection both in various diseases healthy people, necessitate study prevalence populations. In majority conducted epidemiological studies a single recording electrocardiogram (ECG) was used. This is usable method for examination large populations but little informative detecting arrhythmias. The small...
Эпидемиология аритмий (обзор данных литературы) Научные обзоры© ЗАТОНСКАЯ Е. В
Aim. To study the prescription rate of lipid-lowering therapy and achieving target low-density lipoprotein cholesterol (LDL-C) values in outpatients with coronary artery disease (CAD) living Krasnoyarsk. Material methods . The included all patients CAD hospitalized cardiology department clinic Research Institute Medical Problems North (Krasnoyarsk) 2018-2019. analysis data from 1671 (men, 770; women, 901). During hospitalization, an in-depth survey was carried out on subject prescribing...
Обсуждается эффективность и безопасность аторвастатина в снижении риска развития сердечно-сосудистых осложнений.
Aim . To evaluate the volume of antithrombotic therapy (ATT) at prehospital stage in connection with risk thromboembolic complications, and also to study dynamics frequency administration oral anticoagulants (ОAC) patients atrial fibrillation (AF) 2015-2017. Material methods The registry included 562 AF age 18 years older, hospitalized cardiology department during did not include mechanical heart valves, mitral stenosis. diagnosis was established accordance current recommendations. All had...
Aim. To study the relationship of arrhythmias, registered by electrocardiography (ECG) and ECG Holter monitoring, with changes heart disorders its function detected echocardiography in adult population Arctic, living unfavorable environmental conditions. Material methods. Patients (n=348) both sexes, aged 20 years older, were randomly selected examined. All participants carried out recording 12 standard leads, monitoring transthoracic echocardiography. Results. Statistically significant...
The available data convincingly show the presence of multiple pathophysiological links that explain high probability developing metabolic syndrome (MetS) in patients with affective disorders, and MetS itself has been proposed as a premorbid condition depression cardiovascular diseases type 2 diabetes mellitus. aim study was to investigate association depressive disorders its components migrants Far North arterial hypertension after moving new climatic geographical living conditions. Material...
The results of the international multicenter study EMPEROR-Reduced have been discussed on October 31, 2020, at online expert meeting. Considering positive cardiovascular and renal effects empagliflozin, experts supported use empagliflozin in clinical practice to treat patients with chronic heart failure.
The possibility of atorvastatin in reducing the risk periprocedural myocardial infarction and other cardiovascular events patients with percutaneous coronary intervention is discussed.
The possibility of atorvastatin in reducing the risk periprocedural myocardial infarction and other cardiovascular events patients with percutaneous coronary intervention is discussed.
© НЕСТЕРОВА Е. А., ГОГОЛАШВИЛИ Н
High rates of cardiovascular (CV) morbidity and mortality dictates the need to determine approaches therapy that would reduce complications rate improve patient’s prognosis. High-intensity statin is an integral part treatment patients with high very risk. At same time, there a large cohort who benefit from moderate intensity therapy. In present article we have summarized available data on hypolipidemic effects, pleiotropic effects role therapy, atorvastatin particularly, in reding risk major...